Research on the Inhibitory Mechanism of Imazethapyr to Nodule Nitrogenase Activity in Soybean

LI Hui,DING Wei,JIANG Jun-feng,WANG Huai-biao
DOI: https://doi.org/10.3864/j.issn.0578-1752.2013.19.023
2013-01-01
Abstract:【Objective】The objective of this study is to discover the key inhibitory mechanism of imazethapyr to nodule nitrogenase activity in soybean for providing methods to resolve the toxity on nodule nitrogen fixation after imazethapyr being over used.【Method】A field experiment was conducted to determine the relationship between inhibited nodule nitrogenase activity and leghemoglobin content, ammonia content in nodule rhizobium and in nodule cytoplasm after imazethapyr pre-emergence used.【Result】Nodule nitrogenase activity was inhibited more pronounced during 21 days after treatment(DAT). One the 7 and 14 DAT,the inhibited ratio of leghemoglobin content peaked 30.52% and 35.41%, respectively at 112.5 and 25.0 g a.i./hm2imazethapyr and then recovered to the levels of non-treated plants on the 21 and 28 DAT, respectively. The inhibited ratio of ammonia content in nodule rhizobium peaked 35.33% and 48.96%, respectively, on the 14 DAT and recovered to the levels of non-treated plants on the28 DAT. Ammonia content in nodule cytoplasm increased more pronounced and recovered to the normal levels respectively on the 21and 28 DAT.【Conclusion】It is an important reason that leghemoglobin content significantly decreased after imazethapyr pre-emergence applied leads to nodule nitrogenase activity inhibited, and ammonia accumulation in nodule cytoplasm also causes feedback inhibition to nodule nitrogenase.
What problem does this paper attempt to address?